ConductScience.org, home

Paper41513625

RECQL4 promotes the malignant progression of lung adenocarcinoma through the YBX1/G3BP1-mediated NF-κB signaling pathway.

Li R and 9 others. Cell Death Discov, 2026. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. RECQL4 promotes the malignant progression of lung adenocarcinoma through the YBX1/G3BP1-mediated NF-κB signaling pathway. Papers, record 41513625. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41513625

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
RECQL4 promotes the malignant progression of lung adenocarcinoma through the YBX1/G3BP1-mediated NF-κB signaling pathway.
PubMed
Journal
Cell Death Discov
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2026-01-12
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Li RRongyanghttps://orcid.org/0000-0001-6047-3027
2Yu WWenhao
3Wang DDingxin
4Ma LLuyuan
5Tang ZZhanpeng
6Zhu DDingqiang
7Feng ZZitong
8Qi WWenqiang
9Tian HHuihttps://orcid.org/0000-0002-8932-3003
10Gao CCunhttps://orcid.org/0009-0005-4492-9000

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
82472814National Natural Science Foundation of China (National Science Foundation of China)PubMed
ts201712087Taishan Scholar Foundation of Shandong ProvincePubMed

Source PubMed

Download CSV of grants

References37

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
139216548YBX1 as a therapeutic target to suppress the LRP1-β-catenin-RRM1 axis and overcome gemcitabine resistance in pancreatic cancer.Cancer Lett2024https://conductscience.org/library/papers/39216548PubMed
229080750Human RecQL4 helicase plays multifaceted roles in the genomic stability of normal and cancer cells.Cancer Lett2018https://conductscience.org/library/papers/29080750PubMed
339378549Unraveling the mechanisms of RECQL4-mediated cervical cancer progression through the PI3K/AKT pathway.Transl Oncol2024https://conductscience.org/library/papers/39378549PubMed
429364287The biology and management of non-small cell lung cancer.Nature2018https://conductscience.org/library/papers/29364287PubMed
520576703The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function.Nucleic Acids Res2010https://conductscience.org/library/papers/20576703PubMed
631481087The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1- NF-κB signaling axis.J Exp Clin Cancer Res2019https://conductscience.org/library/papers/31481087PubMed
728382490
Silencing of Y-box binding protein-1 by RNA interference inhibits proliferation, invasion, and metastasis, and enhances sensitivity to cisplatin through NF-κB signaling pathway in human neuroblastoma SH-SY5Y cells.
Mol Cell Biochem2017https://conductscience.org/library/papers/28382490PubMed
829379212NF-κB, inflammation, immunity and cancer: coming of age.Nat Rev Immunol2018https://conductscience.org/library/papers/29379212PubMed
927601476Arginine Demethylation of G3BP1 Promotes Stress Granule Assembly.J Biol Chem2016https://conductscience.org/library/papers/27601476PubMed
109632780A novel phosphorylation-dependent RNase activity of GAP-SH3 binding protein: a potential link between signal transduction and RNA stability.Mol Cell Biol1998https://conductscience.org/library/papers/9632780PubMed
1133020468G3BP1 controls the senescence-associated secretome and its impact on cancer progression.Nat Commun2020https://conductscience.org/library/papers/33020468PubMed
1238880223YBX1 promotes homologous recombination and resistance to platinum-induced stress in ovarian cancer by recognizing m5C modification.Cancer Lett2024https://conductscience.org/library/papers/38880223PubMed
1327013200Human Helicase RECQL4 Drives Cisplatin Resistance in Gastric Cancer by Activating an AKT-YB1-MDR1 Signaling Pathway.Cancer Res2016https://conductscience.org/library/papers/27013200PubMed
1419657341RecQ helicases: multifunctional genome caretakers.Nat Rev Cancer2009https://conductscience.org/library/papers/19657341PubMed
1538868333OmicStudio: A composable bioinformatics cloud platform with real-time feedback that can generate high-quality graphs for publication.Imeta2023https://conductscience.org/library/papers/38868333PubMed
168031301Structural and functional properties of the evolutionarily ancient Y-box family of nucleic acid binding proteins.Bioessays1994https://conductscience.org/library/papers/8031301PubMed
1721045146Human RecQL4 helicase plays critical roles in prostate carcinogenesis.Cancer Res2010https://conductscience.org/library/papers/21045146PubMed
1834946868Role and Regulation of the RECQL4 Family during Genomic Integrity Maintenance.Genes (Basel)2021https://conductscience.org/library/papers/34946868PubMed
1931560169Elevated expression of G3BP1 associates with YB1 and p-AKT and predicts poor prognosis in nonsmall cell lung cancer patients after surgical resection.Cancer Med2019https://conductscience.org/library/papers/31560169PubMed
2036922675KIF14 promotes proliferation, lymphatic metastasis and chemoresistance through G3BP1/YBX1 mediated NF-κB pathway in cholangiocarcinoma.Oncogene2023https://conductscience.org/library/papers/36922675PubMed

See all 37 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42698848YBX1 as an adaptive RNA hub in cancer: linking state-dependent RNA regulation to tumor immunity, metabolic reprogramming, and therapy resistance.Front Immunol2026https://conductscience.org/library/papers/42698848PubMed
42327687Differentially Expressed Gene Annotator (DEGAn): automated annotation and analysis of DEGs datasets with OS and PFS data.Bioinform Adv2026https://conductscience.org/library/papers/42327687PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
G3BP110146PubTator's text mininghttps://conductscience.org/library/genes/10146NCBI Gene
NFKB14790PubTator's text mininghttps://conductscience.org/library/genes/4790NCBI Gene
RECQL49401PubTator's text mininghttps://conductscience.org/library/genes/9401NCBI Gene
YBX14904PubTator's text mininghttps://conductscience.org/library/genes/4904NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41513625

GET https://conductscience.org/api/papers/v1/41513625/references?page=2